Markus Wartmann
- Oncology top 1%
- Cancer Treatment and Pharmacology 42
- Cell Biology top 1%
- Microtubule and mitosis dynamics 13
- Molecular Biology top 2%
- Protein Kinase Regulation and GTPase Signaling 8
- Melanoma and MAPK Pathways 7
- Cancer Research top 2%
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis 7
-
- Synthetic Organic Chemistry Methods 25
- Advanced Synthetic Organic Chemistry 12
-
- Chronic Myeloid Leukemia Treatments 7
- Co-authors
- Roger J. DavisJohn L. KnopfLih‐Ling LinAlice LinKarl‐Heinz AltmannTerence O’ReillyDoriano FabbroPaul M.J. McSheehy
- Journals
- Cancer Research (12 papers)Journal of Biological Chemistry (5 papers)Angewandte Chemie International Edition (4 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Markus Wartmann
89 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 2.1k
- Cell Biology 948
- Molecular Biology 3.8k
- Cancer Research 650
- Pharmacology 682
Countries citing papers authored by Markus Wartmann
This map shows the geographic impact of Markus Wartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Wartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Wartmann more than expected).
Fields of papers citing papers by Markus Wartmann
This network shows the impact of papers produced by Markus Wartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Wartmann. The network helps show where Markus Wartmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Wartmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 8 | |
| 2 | 2018 | 1 | |
| 3 | 2013 | 69 | |
| 4 | 2011 | 99 | |
| 5 | 2010 | 125 | |
| 6 | 2009 | 179 | |
| 7 | 2008 | 92 | |
| 8 | 2006 | 37 | |
| 9 | AMN107: Inhibitory profile against non-mutated and mutated forms of the Bcr-Abl tyrosine kinase | 2005 | 2 |
| 10 | 2005 | 39 | |
| 11 | 2005 | 38 | |
| 12 | 2005 | 24 | |
| 13 | Preclinical pharmacological profile of ABJ879, a novel epothilone B analog with potent and protracted anti-tumor activity | 2004 | 8 |
| 14 | A PK-PD dose optimization strategy for the microtubule stabilizing agent ABJ879 | 2004 | 1 |
| 15 | 2004 | 6 | |
| 16 | 2000 | 125 | |
| 17 | 2000 | 159 | |
| 18 | 1997 | 40 | |
| 19 | 1997 | 38 | |
| 20 | 1991 | 15 |
About Markus Wartmann
Markus Wartmann is a scholar working on Oncology, Organic Chemistry, Cell Biology, Hematology and Pharmacology, having authored 89 papers that have together received 6.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (42 papers), Synthetic Organic Chemistry Methods (25 papers), Microtubule and mitosis dynamics (13 papers), Advanced Synthetic Organic Chemistry (12 papers), Protein Kinase Regulation and GTPase Signaling (8 papers), Microbial Natural Products and Biosynthesis (7 papers), Melanoma and MAPK Pathways (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). The work is most often cited by research in Oncology (2.1k citations), Cell Biology (948 citations), Molecular Biology (3.8k citations), Cancer Research (650 citations) and Pharmacology (682 citations). Markus Wartmann has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Roger J. Davis, John L. Knopf, Lih‐Ling Lin, Alice Lin, Karl‐Heinz Altmann, Terence O’Reilly, Doriano Fabbro, Paul M.J. McSheehy, Pascal Furet and Jürgen Mestan. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Angewandte Chemie International Edition, ChemMedChem and CHIMIA International Journal for Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.